Allegheny General Hospital is a large urban hospital located at 320 East North Avenue in Pittsburgh, Pennsylvania, United States. It is part of the larger Allegheny Health Network.

There are 576 beds in Allegheny General Hospital.

During the past decade, Allegheny General Hospital conducted 239 clinical trials. In the 10-year time frame, 239 clinical trials started and 149 clinical trials were completed, i.e. on average, 62.3% percent of trials that started reached the finish line to date. In the past 5 years, 93 clinical trials started and 92 clinical trials were completed. i.e. 98.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allegheny General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 43 trials, followed by "Alliance for Clinical Trials in Oncology" with 28 trials sponsored, "Abbott Medical Devices" with 21 trials sponsored, "NSABP Foundation Inc" with 21 trials sponsored and "United Therapeutics" with 21 trials sponsored. Other sponsors include 315 different institutions and companies that sponsored additional 183 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allegheny General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator, "Genentech, Inc." with 8 trials as a collaborator and "NCIC Clinical Trials Group" with 8 trials as a collaborator. Other collaborators include 310 different institutions and companies that were collaborators in the rest 218 trials.

According to Clinical.Site data, the most researched conditions in "Allegheny General Hospital" are "Pulmonary Arterial Hypertension" (39 trials), "Breast Cancer" (29 trials), "Pulmonary Hypertension" (18 trials), "Coronary Artery Disease" (17 trials) and "Heart Failure" (12 trials). Many other conditions were trialed in "Allegheny General Hospital" in a lesser frequency.

Most popular intervention types in "Allegheny General Hospital" are "Drug" (267 trials), "Device" (106 trials), "Other" (100 trials), "Procedure" (65 trials) and "Biological" (57 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (34 trials), "Questionnaire Administration" (18 trials) and "Docetaxel" (17 trials). Other intervention names were less common.

The vast majority of trials in "Allegheny General Hospital" are 399 trials for "All" genders, 44 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 161 active trials in "Allegheny General Hospital". 1 are not yet recruiting, 77 are recruiting, 81 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 223 completed trials in Allegheny General Hospital, 4 suspended trials, and 43 terminated clinical trials to date.

Out of the total trials that were conducted in Allegheny General Hospital, 12 "Phase 1" clinical trials were conducted, 104 "Phase 2" clinical trials and 198 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 87 trials that are defined as “Not Applicable".

Allegheny General Hospital has several departments that took part in Clinical trials: "Allegheny Cancer Center at Allegheny General Hospital" - 74 trials, "Allegheny Neurological Associates" - 13 trials, "Saint Vincent Consultants in Cardiovascular Diseases" - 10 trials, "Triangle Urological Group" - 7 trials, "West Penn Allegheny Lupus Center of Excellence" - 2 trials, "Women's Behavioral HealthCARE Program" - 2 trials, "Allegheny General Hospital Center for Traumatic Stress in Children and Adolescents" - 2 trials